Shukra Pharmaceuticals Ltd - 524632 - Regulation 32 For Starement Of Deviation

Shukra Pharmaceuticals Ltd.

NSE: RELISH | BSE: 524632 | ISIN: INE551C01044 | Industry: Pharmaceuticals
| Expensive Performer

33.0100 -0.02 (-0.06%)

BSE Jul 21, 2026 10:46 AM

49.42% Fall from 52W High

Volume: 42,773

Shukra Pharmaceuticals Ltd.

07 May 2026

33.01

-0.06%

Company Update

Shukra Pharmaceuticals Ltd - 524632 - Regulation 32 For Starement Of Deviation

BSE India

for the quarter and half year ended march, 2026 the statement of deviation under reg 32

More from Shukra Pharmaceuticals Ltd.

Recommended

Market trades lower, JP Power's Q1 net profit soars 69% YoY

Trendlyne Marketwatch | 21 Jul 2026, 10:50AM

IPO market gathers momentum with a fresh slate of marquee offerings

| 20 Jul 2026, 05:26PM

Five Interesting Stocks Today - July 17, 2026

The Baseline | 17 Jul 2026